CF transmembrane conductance regulator
CFTR is the blueprint for a small door in your cells that lets salt and water out. Cystic fibrosis happens when both copies have a typo that breaks the door. Which typo a person has now decides which medicines can help.
CPIC, the international group that writes gene-based prescribing guidelines, rates how strong the evidence is for each gene and medicine, from A (strong enough to change the prescription) to D (weak or conflicting). Every rating is shown, the weak ones included, so you can see where the evidence stops.
Source: CPIC (Clinical Pharmacogenetics Implementation Consortium), public domain (CC0), copy kept on this site and refreshed weekly.
Showing 200 of 504. Search for all of them.
A child needs a broken copy of CFTR from both parents. A parent with one broken copy is a carrier and is usually healthy.
Medicines such as ivacaftor and Trikafta work on particular kinds of CFTR typos, so the variant decides who they can help.
See CFTR with everything it connects to on the Gene Knowledge Graph, or as data at /api/v1/genes/CFTR.
Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license
CFTR gene. MyGeneLog™. https://www.mygenelog.com/genes/CFTR
A gene page gathers published research; it is not a test result and not medical advice. If a gene matters to your health, talk to a doctor or a genetic counsellor.